HAEMONETICS CORP (HAE)
Surgical & Medical Instruments & Apparatus · Healthcare · $3.4B
Intrinsic Value (Consensus)
$40.59
Current Price
$74.43
Margin of Safety
-45.5%
45.5% Above Intrinsic Value
Value: $41
Price: $74
Valuation Model Estimates
Current Price: $74.43
DCF (Discounted Cash Flow)
$72.97
Graham Number
$28.49
Earnings Power Value
$19.90
Relative Value (P/E)
$41.00
Dividend Discount Model
Not applicable
—
Consensus Value
$40.59
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
D
44
Profitability
18/25
Strength
15/25
Valuation
7/25
Growth
4/25
Financial Health Signals
Elevated debt — Debt/Equity ratio is 156%
Declining revenue — top line is shrinking
Key Financials
- EPS (TTM)
- $2.05
- EPS (Forward)
- $2.09
- Book Value
- $17.60
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- 12.2%
- Debt/Equity
- 156%
- Revenue Growth
- -2.0%
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance